Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates
about
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportSustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbClinical development of Ebola vaccinesEbola virus vaccines: an overview of current approachesAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccineEbola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusAnti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challengeReversion of advanced Ebola virus disease in nonhuman primates with ZMappCamouflage and misdirection: the full-on assault of ebola virus diseaseMolecular mechanisms of Ebola virus pathogenesis: focus on cell death.Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.The multiple roles of sGP in Ebola pathogenesisImmune memory to Sudan virus: comparison between two separate disease outbreaks.Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineA Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionAdenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in MiceDevelopment and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species.In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse.Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impactAdjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityCytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primatesTreatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection.Antibody therapy for Ebola: is the tide turning around?Antibody therapeutics for Ebola virus disease.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infectionCharacterization of host immune responses in Ebola virus infections.Immunology of protection from Ebola virus infection.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.
P2860
Q24289295-9FDCDD49-8F67-48E9-AA9A-7B93BDAEF7FEQ24594601-03AA9B5F-E02D-4416-9294-B38FE5AA36CBQ26775792-15C1CB56-FEA0-4AD0-88A3-17A8A685646FQ26999232-6CA52732-39F0-48B9-90CC-7FE899C7932BQ27334697-DFC956EB-2253-490E-928A-2DECA8690F91Q30234637-DA84526C-C254-4108-A147-BC528553750FQ30235073-23252935-ACA4-4F86-B6EE-0E414CA4FC5DQ30252022-E362903D-7FE0-4365-B48A-3C6473AE228AQ30358243-96D501E9-84A7-4216-A5B3-D5782F6AB1ACQ31152190-4730CDD5-6059-4AD3-925A-BCE8E9D0D9C1Q33715773-3899F8A6-1D03-4F87-90FB-E5512B64E15DQ34361120-74E17E97-7CE8-4BE5-A1F9-13907E7C141DQ34426585-480C8338-D0AB-4935-85BC-E17DDA56BBDBQ34449079-E0A9A78B-D71C-44B1-B157-B6D22FF472AEQ34478514-F8AA89D0-83D2-4706-97DD-ECF801B164D1Q34540207-0ACFC335-976D-4D3A-85F6-4816636A3732Q34869463-232A4332-A3F9-4B24-9AA7-1DA9AC673B87Q35014908-A1F0D487-EFF8-4F21-8826-2ACE0F9BFE06Q35192417-4654ED09-EBCC-4793-9ACA-F1E24786D2AFQ35475259-1C156132-8E37-4953-91EE-348375DB69D4Q35917496-7D1A3DC8-6F82-41CD-8989-29C9DBA978E0Q35917501-44BF691C-0E89-4C2B-B26F-660749208CE5Q36043199-FA968717-8F53-46AC-BF4B-9957087BBF1EQ36043238-B40A13E6-889D-482D-96EC-568350947DB0Q36043258-C15E69B9-55BC-49B1-9177-A34F5AB52947Q36130780-7043F5BF-CCDC-453E-A5C2-794FBBA4A09FQ36178499-D3E0E28C-08F2-4DC8-AEAA-3AC0D11F7686Q36474341-BE9A4D05-B273-40CB-BF9C-0C08F35C6B7DQ36538834-59CE0E40-6313-4EFF-8F37-95F189D92B01Q36580268-B530D09D-1DB9-4074-991D-FD1BF0CAFDD4Q36583281-24153CA1-A457-4425-80AC-55F3A41DF4DBQ36789989-2083A69D-8374-4579-A334-F9ECD0821014Q36977744-909D1796-4E06-4A8D-AB2D-C3F8F8F7FD5FQ36994087-03901524-E9E1-45F6-BB19-D3F19ECA1885Q37627897-A8E4AFFC-EB69-470E-A064-0C8D429D2F16Q37728345-97F6720E-9C70-4327-A2B4-3E04F1FA442AQ38205274-BF431349-12BE-4073-BD4B-C14B26A9DA0DQ38462668-17264453-A52C-4CB0-A899-DD53EE980442Q38524949-65E1D49A-E7EA-4D3B-ACEE-8AAFDF3A46F1Q38674025-4B3274A4-2669-494A-8C4B-CF36E9B4E203
P2860
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune parameters correlate wi ...... rodents and nonhuman primates
@en
Immune parameters correlate wi ...... rodents and nonhuman primates.
@nl
type
label
Immune parameters correlate wi ...... rodents and nonhuman primates
@en
Immune parameters correlate wi ...... rodents and nonhuman primates.
@nl
prefLabel
Immune parameters correlate wi ...... rodents and nonhuman primates
@en
Immune parameters correlate wi ...... rodents and nonhuman primates.
@nl
P2093
P2860
P50
P1476
Immune parameters correlate wi ...... rodents and nonhuman primates
@en
P2093
Ayato Takada
Jason S Richardson
Jeff Hogan
Judie Alimonti
Stéphane Pillet
P2860
P304
P356
10.1126/SCITRANSLMED.3004582
P407
P577
2012-10-01T00:00:00Z